Silver Book Fact

For beneficiaries with wet age-related macular degeneration (AMD), annual Medicare part B payments for vision care increased from $1,504 per beneficiary in 1994 to $3,263 in 2006–due in large part to anti-VEGF treatments.

Day S, Acquah K, Lee P, Mruthyunjaya P, et al. Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007. Ophthalmol. 2011; 152(6): 1014-20. http://www.ajo.com/article/S0002-9394%2811%2900410-7/abstract

Reference

Title
Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007
Publication
Ophthalmol
Publication Date
2011
Authors
Day S, Acquah K, Lee P, Mruthyunjaya P, et al.
Volume & Issue
Volume 152, Issue 6
Pages
1014-20
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Currently an estimated 38 million Americans suffer from blindness, low vision, or an age-related eye disease. That number is expected to grow to around 50 million by 2020.  
  • By 2020, the number of Americans age 40 and older who are blind is projected to reach 1.6 million– growing 70% from 1 million in 2004.  
  • An estimated 4,195,966 Americans age 40 and older have vision impairment and blindness—1,288,275 are blind and 2,907,691 have vision impairment.  
  • Prevalence of Age-Related Eye Disease by Gender and Age  
  • An estimated 51,593 Americans ages 40-49 are blind. That grows to 86,623 at ages 75-79 and just under 1 million for ages 80+.